Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type. Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch. Scope of the Report: This report focuses on the Colloids (Blood Plasma) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The global colloids (blood plasma) industry is mature. The production of Human Albumin increase from 544.08 MT in 2010 to 805.38 MT in 2015, with an average growth rate of more than 9.60 %. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %. The production growth rate of hydroxyethyl starch colloid reduced obviously because Europe and USA banned the usage of HES solutions in patients with sepsis. At the same time, this stimulated the increase of growth rate in albumin colloids. The manufacturers and consumers of natural colloids and synthetic colloids are both concentrated in North America, Europe and China. North America is the largest manufacturer and consumer in natural colloids , however Europe occupies the largest share in the global synthetic market. The worldwide market for Colloids (Blood Plasma) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers CSL Behring Baxter Grifols Octapharma Kedrion Shanghai Raas CTBB Hualan Bio Rongsheng Pharmaceutical Boya Rongsheng B. Braun Medical Fresenius Kabi HOSPIRA Axa parenterals Fresenius Kabi(China) CR Double-Crane Kelun Group Shandong Qidu Pharmaceutical Shandong Hualu Pharmaceutical Minsheng Pharma Kanglepharm Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Natural Type Colloids (Blood Plasma) Synthetic Type Colloids (Blood Plasma) Market Segment by Applications, can be divided into Extensive Burns Massive Blood or Plasma Loss Hypovolemic Shock Others There are 15 Chapters to deeply display the global Colloids (Blood Plasma) market. Chapter 1 to describe Colloids (Blood Plasma) Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Colloids (Blood Plasma), with sales, revenue, and price of Colloids (Blood Plasma), in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Colloids (Blood Plasma), for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Colloids (Blood Plasma) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Colloids (Blood Plasma) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Colloids (Blood Plasma) Introduction 1.2 Market Analysis by Type 1.2.1 Natural Type Colloids (Blood Plasma) 1.2.2 Synthetic Type Colloids (Blood Plasma) 1.3 Market Analysis by Applications 1.3.1 Extensive Burns 1.3.2 Massive Blood or Plasma Loss 1.3.3 Hypovolemic Shock 1.3.4 Others
